Edwards Lifesciences
We're hiring — explore open roles below and apply in a few clicks.
Location
Headquarters: Irvine, California, United States, North America
Region: California
Country: US
Continent: North America
About
Edwards Lifesciences is a global medical technology company focused on cardiovascular disease, specializing in innovative heart valve therapies and related products. The company offers transcatheter and surgical heart valve technologies, advanced tissue solutions, and implantable therapies with a patient-centered approach. It operates internationally, providing resources for patients, clinicians, and healthcare professionals, and emphasizes research, education, and corporate responsibility. Edwards Lifesciences is known for leadership in structural heart disease innovation and for serving patients worldwide.
Edwards Lifesciences is a global medical technology company specializing in cardiovascular disease solutions. It develops and manufactures transcatheter and surgical heart valves, advanced tissue solutions, and hemodynamic monitoring products for healthcare providers. The company serves patients and clinicians worldwide with a focus on structural heart disease innovation.
Edwards Lifesciences Corporation
1958
for_profit
active
Industries
Primary Industry: Business Services
Categories
Funding & Financials
Public Company
382300000
over-1b
ipo
EW
nasdaq
Founders
Miles Edwards
Leadership
Murali Reddi — Principal, Medical Safety Officer
Shane Gleason — Senior Director, US Marketing- Transcatheter Heart Valves
Uzair Siddiqui — Leader, Strategic Program Management
Nikolas Rizos — Strategy / Business Intelligence TMTT EU
Farzad Azimpour — Senior Vice President, Strategic Innovation, Advanced Technology
Harry Rowland — SVP of IHFM Innovation
Nolan Sardesai — Sr. Product Manager
William J. Link — board_member
Michael A. Mussallem — board_member
Ramona Sequeira — board_member
Nicholas Valeriani — board_member
Technology Stack
Products
Transcatheter Heart Valves: Devices implanted via catheter to replace diseased aortic heart valves without open-heart surgery.
Transcatheter Mitral and Tricuspid Technologies: Catheter-delivered devices for treating mitral and tricuspid valve diseases without open surgery.
Surgical Valve Technologies: Heart valve replacement and repair devices used in traditional open-heart surgical procedures.
Funding rounds
IPO · (2000-04-03)
Connect
Connect
Open positions(5)
- Senior CMDB DeveloperPremiumFull-timeWork from OfficeIndia-Pune
- Senior CMDB DeveloperFull-timeWork from OfficeIndia-Pune
- Associate Web Developer, ITFull-timeWork from OfficeIndia-Pune
- Senior Data ScientistPremiumFull-timeWork from OfficeUSA - California – Irvine108,000–153,000 / Year
- Staff Data ScientistFull-timeWork from OfficeUSA - California – Irvine126,000–178,000 / Year